Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,829 | -63,205 | -290,023 | -155,945 | -205,743 |
| Depreciation Amortization | 6,747 | 3,512 | 17,291 | 13,673 | 10,402 |
| Accounts receivable | -16,200 | -26,481 | 25,180 | 6,131 | 17,868 |
| Accounts payable and accrued liabilities | 4,192 | 10,207 | 805 | -1,115 | -1,013 |
| Other Working Capital | 54,613 | 34,375 | 60,083 | 36,323 | 60,727 |
| Other Operating Activity | 44,937 | 33,116 | 104,432 | 73,661 | 46,232 |
| Operating Cash Flow | $-41,540 | $-8,476 | $-82,232 | $-27,272 | $-71,527 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -51,741 | -13,530 | -479,930 | -393,909 | -262,647 |
| PPE Investments | -2,537 | -1,638 | -5,186 | -3,790 | -2,215 |
| Sale Of Investment | 132,518 | 76,103 | 83,144 | 46,294 | 10,610 |
| Purchase Sale Intangibles | -35,000 | -35,000 | -25,000 | -25,000 | 0 |
| Other Investing Activity | -35,000 | -35,000 | -25,000 | -25,000 | 0 |
| Investing Cash Flow | $43,240 | $25,935 | $-426,972 | $-376,405 | $-254,252 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -224 | -102 | -5,892 | -5,661 | -5,527 |
| Common Stock Issued | 2,779 | 183 | 12,701 | 11,863 | 11,756 |
| Other Financing Activity | -3,361 | -2,974 | -7,372 | -6,734 | -5,928 |
| Financing Cash Flow | $-806 | $-2,893 | $-563 | $-532 | $301 |
| Exchange Rate Effect | -4,359 | 107 | 2,597 | 343 | 446 |
| Beginning Cash Position | 171,223 | 171,223 | 678,393 | 678,393 | 678,393 |
| End Cash Position | 167,758 | 185,896 | 171,223 | 274,527 | 353,361 |
| Net Cash Flow | $-3,465 | $14,673 | $-507,170 | $-403,866 | $-325,032 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,540 | -8,476 | -82,232 | -27,272 | -71,527 |
| Capital Expenditure | -2,543 | -1,638 | -5,186 | -3,790 | -2,215 |
| Free Cash Flow | -44,083 | -10,114 | -87,418 | -31,062 | -73,742 |